Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lopez J, 2008, Diagnostic errors and temporal stability in bipolar disorder, Actas Esp Psiquiatr, 36, 205
CutlerA DattoC NordenhemAet al.Effectiveness of extended‐release formulation of quetiapine as monotherapy for the treatment of acute bipolar mania (trial D144CC00004) [abstract NR3‐006]. Annual meeting of the American Psychiatric Association. Washington D.C. 2008.
Vieta E, 2008, New Research Abstracts, Annual Meeting of the American Psychiatric Association
CutlerAA randomized double‐blind placebo‐controlled parallel‐group dose‐response multicenter study to evaluate the efficacy and safety of three fixed doses of extended‐release paliperidone (3 6 and 12 mg/day) in the treatment of subjects with acute manic and mixed episodes associated with bipolar I disorder. Veritas Medicine. January 7 2008. Available at:http://www.download.veritasmedicine.com/PDF/CR010834_CSR.pdf. Accessed February 11 2009.
Hirschfeld R, 2007, New Research Abstracts, Annual Meeting of the American Psychiatric Association
Panagides J, 2007, Asenapine in acute mania: a randomized, double‐blind, placebo‐ and olanzapine‐controlled trial (ARES 7501004), Biol Psychiatry, 61, 222S
McIntyre R, 2008, Asenapine in the treatment of acute mania in bipolar I disorder: outcomes from two randomized placebo‐controlled trials, Bipolar Disord, 10, 49
Calabrese J, 2008, New Research Abstracts, Annual Meeting of the American Psychiatric Association
Kulkarni J, 2008, Tamoxifen – a potential treatment for women in the manic phase of bipolar affective disorder?, Bipolar Disord, 10, 80
Thomas P, 2008, Amisulpride plus valproate vs haloperidol plus valproate in the treatment of acute mania of bipolar I patients: a multicenter, open‐label, randomized, comparative trial, Neuropsychiatr Dis Treat, 4, 1
RiesenbergR.A randomized double‐blind placebo‐controlled parallel‐group multicenter study to evaluate the efficacy and safety of flexibly‐dosed extended‐release paliperidone as adjunctive therapy to mood stabilizers in the treatment of acute manic and mixed episodes associated with bipolar I disorder. Veritas Medicine. Feb 25 2008. Available at:http://www.download.veritasmedicine.com/PDF/CR010855_CSR.pdf. Accessed February 11 2009.
Young A, 2008, New Research Abstracts, Annual Meeting of the American Psychiatric Association
Olausson B, 2008, New Research Abstracts, Annual Meeting of the American Psychiatric Association
Suppes T, 2008, New Research Abstracts, Annual Meeting of the American Psychiatric Association
Muzina D, 2008, New Research Abstracts, Annual Meeting of the American Psychiatric Association
Justo LP, 2007, Family interventions for bipolar disorder, Cochrane Database Syst Rev
Parikh S, 2007, New Research Abstracts, Annual Meeting of the American Psychiatric Association
YoungA McElroyS OlaussonBet al.Quetiapine Monotherapy up to 52 weeks in patients with bipolar depression: continuation phase data from EMBOLDEN I & II [Abstract]. Barcelona Spain:21st ENCP Conference 2008.
Nolen W, 2008, New Clinical Data in the Maintenance Treatment of Bipolar Disorder
Vieta E, 2008, Efficacy and safety of quetiapine in combination with lithium/divalproex as maintenance treatment for bipolar I disorder, Bipolar Disord, 10, 57
Suppes T, 2008, Maintenance treatment in bipolar I disorder with quetiapine concomitant with lithium or divalproex: a placebo‐controlled, randomized multicenter trial (Trial D1447C00127), Bipolar Disord, 10, 40
Brecher M, 2008, New Research Abstracts, Annual Meeting of the American Psychiatric Association
Yatham LN, 2008, Current Maintenance Treatments for Bipolar Disorder
Forbes A, 2008, New Research Abstracts, Annual Meeting of the American Psychiatric Association
Vieta E, 2009, 17th European Congress of Psychiatry
Food and Drug Administration.Information for Healthcare Professionals. Lamotrigine (marketed as Lamictal). Jan 31 2008. Available at:http://www.fda.gov/CDER/drug/InfoSheets/HCP/lamotrigineHCP.htm. Accessed January 24 2009.
Farías M, 2007, Adaptación de la Escala Highs para la detección de sintomatología hipomaníaca en el puerperio, Trastor Ánimo, 3, 27
DelBello M, 2008, New Research Abstracts, Annual Meeting of the American Psychiatric Association
Forbes A, 2008, New Research Abstracts, Annual Meeting of the American Psychiatric Association
Tramontina S, 2007, Aripiprazole in juvenile bipolar disorder comorbid with attention‐deficit/hyperactivity disorder: an open clinical trial, CNS Spectr, 12, 758, 10.1017/S1092852900015443
Sheehan DV, 2008, Randomized, placebo‐controlled trial of risperidone for acute treatment of bipolar anxiety, J Affect Disord
Liebowitz M, 2008, New Research Abstracts, Annual Meeting of the American Psychiatric Association
Ketter TA, 2007, Divalproex‐extended release monotherapy and adjunctive therapy in bipolar II depression, Bipolar Disord, 9, 58
Aaronson S, 2008, New Research Abstracts, Annual Meeting of the American Psychiatric Association
Jung I, 2008, Lamotrigine treatment for patients with bipolar II disorder: retrospective report of 30 cases, Bipolar Disord, 10, 45
Suppes T, 2007, Awareness of metabolic concerns and perceived impact of pharmacotherapy in patients with bipolar disorder: a survey of 500 US psychiatrists, Psychopharmacol Bull, 40, 22
Jakovljevic M, 2007, Mental disorders and metabolic syndrome: a fatamorgana or warning reality?, Psychiatr Danub, 19, 76
Food and Drug Administration.Information for Healthcare Professionals: Carbamazepine. Available at:http://www.fda.gov/cder/drug/InfoSheets/HCP/carbamazepineHCP.htm. Accessed January 24 2009.